Arkolith/Insider Trading/TXG/Form 4

Taich Adam

Chief Financial Officer10x Genomics, Inc. (TXG) · full profile →Form 4 · filed Mar 19, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 17, 2025Grant(A)134K—$0336K
Oct 23, 2024Grant(A)202K—$0202K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001610717-25-000073) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML